Data / Drug companies / Metoclopramide hydrochloride
Metoclopramide hydrochloride: 13 companies and 17 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Metoclopramide hydrochloride is listed in the FDA National Drug Code Directory by 13 companies, with 17 products in commercial distribution. 14 of the products (82.4%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are solution; injection, solution; injection, and the newest product started marketing on April 30, 2026.
The request: Get every company that lists metoclopramide hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 13
- Products
- 17
- Generic (ANDA) products
- 14 (82.4%)
- Application numbers
- 7
- Routes
- Oral, Intramuscular, Intravenous, Nasal
- Brand names
- Metoclopramide, Reglan, Metoclopramide, Gimoti
- openFDA record search
- api.fda.gov
Companies that list metoclopramide hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Ani Pharmaceuticals, Inc. | 2 | tablet | New drug applications (NDA) | July 5, 2011 |
| Fresenius Kabi USA, LLC | 2 | injection, solution | Generic drugs (ANDA) | May 3, 2013 |
| Lupin Pharmaceuticals,Inc. | 2 | tablet, orally disintegrating | Generic drugs (ANDA) | April 6, 2015 |
| Pai Holdings, LLC DBA Pai Pharma | 2 | solution | Generic drugs (ANDA) | June 1, 1991 |
| Atlantic Biologicals Corp. | 1 | solution | Generic drugs (ANDA) | June 1, 1991 |
| Avenacy, LLC | 1 | injection, solution | Generic drugs (ANDA) | June 30, 2024 |
| Chartwell Governmental & Specialty RX, LLC. | 1 | solution | Generic drugs (ANDA) | October 27, 1992 |
| Chartwell RX, LLC | 1 | solution | Generic drugs (ANDA) | October 27, 1992 |
| Evoke Pharma, Inc. | 1 | spray | New drug applications (NDA) | June 19, 2020 |
| Genus Lifesciences | 1 | solution | Generic drugs (ANDA) | June 1, 2024 |
| Henry Schein, Inc. | 1 | injection | Generic drugs (ANDA) | April 30, 2026 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 1 | injection | Generic drugs (ANDA) | January 3, 2014 |
| Medical Purchasing Solutions, LLC | 1 | injection | Generic drugs (ANDA) | January 3, 2014 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Solution | 6 | 35.3% |
| Injection, solution | 3 | 17.6% |
| Injection | 3 | 17.6% |
| Tablet, orally disintegrating | 2 | 11.8% |
| Tablet | 2 | 11.8% |
| Spray | 1 | 5.9% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 14 | 82.4% |
| New drug applications (NDA) | 3 | 17.6% |
Pharmacologic classes
| Class | Products |
|---|---|
| Dopamine-2 Receptor Antagonist | 17 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.